Bibliography
- Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007;73(2):137-50
- Pexton T, Moeller-Bertram T, Schilling JM, Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin Investig Drugs 2011;20(9):1277-84
- Boschen MJ. A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder. Can J Psychiatry 2011;56(9):558-66
- Feltner DE, Liu-Dumaw M, Schweizer E, Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study. Int Clin Psychopharmacol 2011;26(4):213-20
- Di Nicola M, Tedeschi D, Martinotti G, Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series. J Clin Psychopharmacol 2011;31(5):675-7
- Oulis P, Florakis AA, Tzanoulinos G, Adjunctive pregabalin to quetiapine in acute mania. Clin Neuropharmacol 2009;32(3):174
- Pae CU. Pregabalin augmentation to antidepressants in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(3):577-8
- Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 2005;28(2):187-93
- Forg A, Hein J, Volkmar K, Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial. Alcohol Alcohol 2012;47(2):149-55
- Martinotti G, di Nicola M, Frustaci A, Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction 2010;105(2):288-99
- Martinotti G, Di Nicola M, Tedeschi D, Efficacy and safety of pregabalin in alcohol dependence. Adv Ther 2008;25(6):608-18
- Martinotti G, Di Nicola M, Tedeschi D, Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. J Psychopharmacol 2010;24(9):1367-74
- Stopponi S, Somaini L, Cippitelli A, Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat. Psychopharmacology (Berl) 2012;220(1):87-96
- Bobes J, Rubio G, Teran A, Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice. Eur Psychiatry 2011; Published online 18 February 2011
- Oulis P, Konstantakopoulos G, Kouzoupis AV, Pregabalin in the discontinuation of long-term benzodiazepines' use. Hum Psychopharmacol 2008;23(4):337-40
- Harmark L, van Puijenbroek E, Straus S, Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information. Drug Saf 2011;34(3):221-31
- Cabrera J, Emir B, Dills D, Characterizing and understanding body weight patterns in patients treated with pregabalin. Curr Med Res Opin 2012; Published online 12 April 2012
- Schwan S, Sundstrom A, Stjernberg E, A signal for an abuse liability for pregabalin–results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol 2010;66(9):947-53
- Schifano F, D'Offizi S, Piccione M, Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom 2011;80(2):118-22
- Schifano F, Leoni M, Martinotti G, Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project. Cyberpsychol Behav 2003;6(4):405-10
- Einarsdottir S, Bjornsson E. Pregabalin as a probable cause of acute liver injury. Eur J Gastroenterol Hepatol 2008;20(10):1049